Sandy Keenan edits Viewpoint and news articles for Spectrum. She is a New York-based journalist who has enjoyed a richly varied career — as reporter, editor and newsroom manager — with The New York Times and Newsday. She started out as a sportswriter for the Miami Herald, then moved on to Sports Illustrated and then Newsday, where she transitioned from covering Knicks, Mets and Yankees games on deadline into editing and over to news. She eventually became Newsday‘s assistant managing editor in charge of news, investigations and narrative projects. More recently, with the Times, she served as environment editor, deputy sports editor and a staff writer for the Home & Garden section.
Sandy Keenan
Contributing Editor
Spectrum
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”